Mentioned On
Episode Mentions
Pharma and BioTech Daily · Apr 30, 2026
AstraZeneca's £300M UK Investment Resumes Amid FDA Pilot | Pharma and Biotech Daily
“Preparing for potential FDA approval of next-generation CAR-T therapy for multiple myeloma treatment”
FDA Real-Time Clinical Trial Review PilotAstraZeneca UK Investment and Drug PricingOncology Market Consolidation Strategy
View AnalysisPharma and BioTech Daily · Apr 29, 2026
AstraZeneca's Breztri Asthma Approval Boosts $80B Goal | Pharma and Biotech Daily
“Gilead Sciences subsidiary advancing next-generation CAR-T cell therapy for multiple myeloma”
FDA Drug Approval and RescissionData Integrity in Drug DevelopmentAI-Designed Therapeutics
View Analysis